Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predicting Onset of COVID-19 with Mobility-Augmented SEIR Model

View ORCID ProfileNeo Wu, Xue Ben, Bradley Green, Kathryn Rough, Srinivasan Venkatramanan, Madhav Marathe, Paul Eastham, Adam Sadilek, Shawn O’Banion
doi: https://doi.org/10.1101/2020.07.27.20159996
Neo Wu
1Google Research, Google LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Neo Wu
  • For correspondence: neowu@google.com sadilekadam@google.com obanion@google.com
Xue Ben
1Google Research, Google LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley Green
1Google Research, Google LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Rough
1Google Research, Google LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Srinivasan Venkatramanan
2Biocomplexity Institute and Initiative, University of Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madhav Marathe
2Biocomplexity Institute and Initiative, University of Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Eastham
1Google Research, Google LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Sadilek
1Google Research, Google LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: neowu@google.com sadilekadam@google.com obanion@google.com
Shawn O’Banion
1Google Research, Google LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: neowu@google.com sadilekadam@google.com obanion@google.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Timely interventions and early preparedness of healthcare resources are crucial measures to tackle the COVID-19 disease. To aid these efforts, we developed the Mobility-Augmented SEIR model (MA-SEIR) that leverages Google’s aggregate and anonymized mobility data to augment classic compartmental models. We show in a retrospective analysis how this method can be applied at an early stage in the COVID-19 epidemic to forecast its subsequent spread and onset in different geographic regions, with minimal parameterization of the model. This provides insight into the role of near real-time aggregate mobility data in disease spread modeling by quantifying substantial changes in how populations move both locally and globally. These changes would be otherwise very hard to capture using less timely data.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All data are anonymized and sufficiently aggregated.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We do not share any data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predicting Onset of COVID-19 with Mobility-Augmented SEIR Model
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predicting Onset of COVID-19 with Mobility-Augmented SEIR Model
Neo Wu, Xue Ben, Bradley Green, Kathryn Rough, Srinivasan Venkatramanan, Madhav Marathe, Paul Eastham, Adam Sadilek, Shawn O’Banion
medRxiv 2020.07.27.20159996; doi: https://doi.org/10.1101/2020.07.27.20159996
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Predicting Onset of COVID-19 with Mobility-Augmented SEIR Model
Neo Wu, Xue Ben, Bradley Green, Kathryn Rough, Srinivasan Venkatramanan, Madhav Marathe, Paul Eastham, Adam Sadilek, Shawn O’Banion
medRxiv 2020.07.27.20159996; doi: https://doi.org/10.1101/2020.07.27.20159996

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)